Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 16, 2007

IBM to Manage IT Services for AstraZeneca in $1.4B Alliance

  • IBM signed a $1.4-billion, seven-year outsourcing agreement with AstraZeneca. The deal renews and expands on the scope of an existing contract and covers the provision of IT infrastructure services to 60 countries.

    “Leveraging IBM's global delivery capabilities and economies of scale will allow AstraZeneca to focus its efforts on adding value to its scientific, commercial, and supply operations, thereby helping the company to deliver more medicines that make a meaningful difference to patients,” notes Richard Williams, CIO of AstraZeneca. “In allowing IBM greater autonomy on methods of delivery, the agreement will result in cost efficiencies when compared with running in-house systems."

    IBM will provide a single global technical infrastructure, managing IT services for AstraZeneca across its global organization. This includes server and storage hosting, service desks, PC management, network and communications services, including e-mail, and computer operations support. AstraZeneca will retain control of its overall IT strategy and the development and support of its application systems.

    "This innovative agreement with IBM will enable AstraZeneca to deliver greater value to the business by providing consistent infrastructure services globally, enabling a faster and more efficient rollout of new technology with improved levels of service,” according to Williams.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »